HFSA: Clinical Benefits Tied to Lung Monitoring Persist HF rehospitalization, deaths remain reduced up to 4.5 years
ORLANDO — The clinical benefits observed with using a monitoring device for lung congestion were maintained in the longer run, according to results from the IMPEDANCE-HF trial.